Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve C-N coupling challenges with one-pot fluorosulfonate-amine process: no separation steps, high purity, and cost efficiency. Request a quote today.
Solve 2-amino-5-chloropyridine supply chain risks with 98.8% yield, no dichloro byproducts, and recyclable ionic liquid catalysts. Reduce costs and EHS risks for zopiclone production.
Discover high-purity axial chiral cyclopentenyl indole-naphthyl compounds with 99% ee for PC-3 cancer cell cytotoxicity. Optimize your drug development with scalable synthesis.
Discover how axial chiral bisindole catalysts with >95:5 er enable scalable asymmetric synthesis, reducing R&D costs and supply chain risks for pharmaceutical intermediates.
Solve low-yield issues in coumarin synthesis with 97%+ yields. Our CDMO expertise scales this patent-protected method for stable API supply chains.
Solve C-S bond formation challenges with air-stable indole phosphine ligands. 0.5 mol% catalyst, 90% yield. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Discover how palladium-catalyzed carbonylation enables efficient indole-3-carboxamide synthesis with 85-92% yield, reducing production costs and supply chain risks for pharmaceutical intermediates.
Discover how asymmetric Povarov reaction with cobalt catalysts enables high-yield, enantioselective synthesis of chiral tetrahydroquinolines for drug development.
Solve high-toxicity metal cyanide issues in aryl acetonitrile production. Our catalyst-free method offers 91% yield, air-stable operation, and scalable manufacturing for drug development.
Solve metal residue issues in 3-thioindole production. 70% yield, no transition metals, room-temperature process. CDMO expertise for scalable API synthesis.
Discover a cost-effective, air-stable synthesis for trifluoromethyl 1,2,4-triazine compounds. Eliminate heavy metal catalysts and nitrogen protection, ensuring supply chain reliability for your API production.
Solve high cost & low yield in ezetimibe production. New chiral catalyst method cuts steps, boosts 86% yield & 99.8% purity. Scale with CDMO expertise.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Solve high-cost, low-yield issues in Ribociclib production. Our CDMO leverages patent-validated metal-free routes for 99.8% purity, 5-step synthesis, and scalable manufacturing.
Discover efficient synthesis of axial chiral indole-naphthalene compounds with >95% ee. Reduce production costs and scale up asymmetric catalysts for pharma R&D.
Solve high catalyst cost & low ee in chiral α-aminophosphonic acid synthesis. Our CDMO expertise delivers 99% ee with 0.0001% catalyst loading. Scale to 100 MT/yr.
Discover a novel palladium-catalyzed method for direct construction of two connected tertiary carbon bonds with high yield and optical purity. Ideal for pharmaceutical and fine chemical manufacturing.
Solve high-cost metal catalysts with 97% yield dioxa[5]helicene synthesis. NINGBO INNO PHARMCHEM offers scalable, functional-group-tolerant production for optoelectronic applications.
Solve high catalyst costs and iodine raw material issues in boscalid production. Our CDMO expertise enables scalable, low-cost manufacturing for agrochemicals.
Boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis with our large steric hindrance catalysts. Reduce costs, ensure GMP compliance, and scale efficiently. Contact us for custom synthesis.